<DOC>
	<DOCNO>NCT01430949</DOCNO>
	<brief_summary>The Genesis Feasibility Study collect clinical information use Bard Over-the-Wire Mesh Ablation System access perform electrophysiological mapping , cardiac stimulation radiofrequency ablation region pulmonary vein ( PV ) ostia treatment patient Paroxysmal Atrial Fibrillation . Patients follow 12 month assess primary safety endpoint Major Complications ( composite safety endpoint ) effectiveness , define Long-Term Success ( freedom recurrent atrial arrhythmia .</brief_summary>
	<brief_title>GENESIS Feasibility Study BARD Over-the-Wire Mesh Ablation System Treatment Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common sustain arrhythmia see physician . Its prevalence population increase age , estimate affect 4 % population age 60 . Common approach AF management include use anti-arrhythmic drug control arrhythmia . An alternative treatment AF use drug therapy ablation cardiac tissue , goal disrupt aberrant electrical pathway cause AF creation ablation lesion within left atrium . There several different approach create lesion treat AF , although substrate derive focal AF mechanism share common ablation therapy protocol PVs isolate series ablation line place endocardially , either around PV ostia proximally PV ostia atrial carina . The Over-the-Wire Mesh Ablation System ( OTW MAS ) catheter combine map ablation catheter design create lesion PV ostium . The Genesis Feasibility Study design collect clinical information use OTW MAS access perform electrophysiological mapping , cardiac stimulation radiofrequency ablation region pulmonary vein ( PV ) ostia treatment patient Paroxysmal Atrial Fibrillation ( PAF ) .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic PAF refractory least one Class IIV antiarrhythmic drug . Minimum one document PAF episode &gt; 30 sec duration within prior 12 month . Minimum three PAF episodes prior 12 month . 18 year old . AF due reversible cause . More 2 cardioversions 6 month Previous surgical catheter base ablation LA treat AF . Permanent persistent AF . Requirement ablation lesion define protocol LA &gt; 50 mm major dimension ( measure TTE ) . Any single PV &gt; 25 mm major diameter and/or presence common o suitable ablation Ejection fraction &lt; 35 % . Patent foramen ovale ( PFO ) atrial septal defect ( ASD ) Cardiac myopathy ( e.g. , HOCM , cardiac sarcoidosis ) . Myocardial infarction previous 2 month screen . Currently unstable angina . Any cardiac surgery previous 3 month prior screen . Implantable device capable record cardiac rhythm , ( e.g ICD , pacemaker implantable loop recorder . Clinically significant valvular heart disease replacement heart valve . Congestive heart failure ( NYHA classification III IV ) . Renal dialysis creatinine &gt; 2.0 mg/dl . Contraindication anticoagulation therapy ( e.g. , warfarin , heparin ) . Contraindication transseptal procedure . Any cerebral ischemic event , include TIA 6 month prior screen . Any known uncontrolled bleeding thrombotic disorder . Women know pregnant nursing . Uncontrolled hyperthyroidism . Patients currently enrol study 30 day prior screen . Any significant uncontrolled unstable medical condition ( e.g. , active systemic infection ) . A life expectancy le one year . Currently document intracardiac thrombus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Paroxysmal Atrial Fibrillation</keyword>
	<keyword>Catheter Ablation</keyword>
	<keyword>Pulmonary Vein Isolation</keyword>
	<keyword>Radio Frequency Ablation</keyword>
</DOC>